Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
CTX:WSE
Captor Therapeutics SA
PLN 80.00
+1.01%
(+0.80) 1D
Apr 29, 1:37:15 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for CTX...
Open
PLN 79.20
High
PLN 81.00
Low
PLN 79.20
Mkt. cap
508.27M
Avg. vol.
5.08K
Volume
428.00
52-wk high
PLN 89.20
52-wk low
PLN 31.20
EPS
-PLN 7.68
Shares outstanding
6.35M
No. of employees
91
News stories
From sources across the web
About Captor Therapeutics SA
CEO-
Employees91
Founded2015
Headquarters-
SectorBiotechnology
Last report
Sep 12, 2025
Fiscal Period
Q2 2025
Normalized EPS / Estimate
-/ -PLN
Revenue / Estimate
4.62M/ (3.60M est.)PLN
+28.22%beat
Fiscal Q2 2025 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Revenue
2.95M
2.61M
2.01M
-
Cost of goods sold
1.18M
873.00K
2.59M
-2.02M
Cost of revenue
1.18M
873.00K
2.59M
-2.02M
Research and development expenses
14.36M
10.54M
10.19M
14.74M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-1.60M
2.89M
4.35M
1.37M
Operating expense
10.56M
12.45M
10.16M
13.83M
Total operating expenses
11.74M
13.32M
12.76M
11.81M
Operating income
-8.79M
-10.72M
-10.74M
-11.81M
Other non operating income
-1.00K
-1.00K
-
1.00K
EBT including unusual items
-8.76M
-10.72M
-9.76M
-11.48M
EBT excluding unusual items
-8.76M
-10.72M
-9.76M
-11.48M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-2.20M
-976.00K
-4.38M
-2.27M
Net income
-8.76M
-10.72M
-9.76M
-11.48M
Net profit margin
-296.55%
-411.32%
-485.32%
-
Earnings per share
-
-
-
-
Interest and investment income
167.00K
275.00K
847.00K
391.00K
Interest expense
-124.00K
-103.00K
-36.00K
-61.00K
Net interest expenses
43.00K
172.00K
811.00K
330.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.52M
-9.49M
-9.43M
-10.81M
Gain or loss from assets sale
-
-
682.00K
-682.00K
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more